Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 2/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.65 |
| ▸ | MEN1 | O00255 | 2/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.65 |
| ▸ | MAPT | P10636 | 1/20 | 0.65 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.38 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.38 |
| ▸ | ALDH1A2 | O94788 | 1/20 | 0.34 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.34 |
| ▸ | ALDH1A3 | P47895 | 1/20 | 0.34 |
| ▸ | CNR1 | P21554 | 1/20 | 0.33 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.32 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.32 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.32 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1399147 | 0.81 | USP2 (0.60) | USP2ALDH1A1MEN1KMT2AMAPT | |
| SCHEMBL8895646 | 0.79 | ALDH1A1 (0.58) | USP2ALDH1A1MEN1KMT2AMAPT | |
| SCHEMBL14602775 | 0.79 | USP2 (1.00) | USP2ALDH1A1MEN1KMT2AMAPT | |
| SCHEMBL3871043 | 0.79 | USP2 (1.00) | USP2ALDH1A1MEN1KMT2AMAPT | |
| SCHEMBL6732293 | 0.79 | ALDH1A1 (0.64) | USP2ALDH1A1MEN1KMT2AMAPT | |
| SCHEMBL8895535 | 0.79 | USP2 (1.00) | USP2ALDH1A1MEN1KMT2AMAPT | |
| SCHEMBL20090834 | 0.78 | USP2 (0.56) | USP2ALDH1A1MEN1KMT2AMAPT | |
| SCHEMBL18783177 | 0.78 | ALDH1A1 (0.56) | USP2ALDH1A1MEN1KMT2AMAPT | |
| SCHEMBL525215 | 0.77 | ALDH1A1 (0.61) | USP2ALDH1A1MEN1KMT2AMAPT | |
| SCHEMBL4255667 | 0.76 | USP2 (0.74) | USP2ALDH1A1MEN1KMT2AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120258061-A1 | Method for Treating Skin with Retinoids and Retinoid Boosters | CONOPCO, INC., D/B/A UNILEVER (US) | 2012-10-11 | — | — | US | disclosed |
| US-8226933-B2 | Method for treating skin with booster compositions | UNILEVER HOME & PERSONAL CARE, USA DIVISION OF CONOPCO, INC. (US) | 2012-07-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120258061-A1 | Method for Treating Skin with Retinoids and Retinoid Boosters | RARA, RARG, RARB | USP2 2070/4885ALDH1A1 412/4885MEN1 4792/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.